Author information:
(1)Department of Pharmacy, Tan Tock Seng Hospital, Singapore.
(2)Department of Geriatric Medicine, Changi General Hospital, Singapore.
(3)Department of Nursing, Changi General Hospital, Singapore.
(4)Department of Pharmacy, Changi General Hospital, Singapore.
(#)Contributed equally

INTRODUCTION: Polypharmacy and inappropriate prescribing are associated with 
negative health outcomes in the elderly. Several prescribing tools have been 
developed to assess medication appropriateness. Explicit (criteria-based) tools 
often do not take into account patients' preferences and comorbidities, and have 
little room for individualised clinical judgement.
METHODS: A cross-sectional observational study was conducted in 243 elderly 
patients admitted to the Geriatric Medicine service in a Singapore tertiary 
hospital over one month. We incorporated an implicit (judgement-based) tool 
developed by Scott et al into a mnemonic, 'S-I-R-E', to assess medication 
appropriateness: S = symptoms ('Have symptoms resolved?'), I = indication ('Is 
there a valid indication?'), R = risks ('Do risks outweigh benefits?') and E = 
end of life ('Is there short life expectancy limiting clinical benefit?').
RESULTS: Inappropriate prescribing was present in 27.6% of patients. The most 
common reason for inappropriateness of medications was lack of valid indication 
(62.2%), followed by high risk-benefit ratio (20.7%). The most common 
medications that lacked valid indication were supplements and proton pump 
inhibitors. Polypharmacy was found in 93% of patients and was significantly 
associated with inappropriate prescribing (p = 0.047).
CONCLUSION: Inappropriate prescribing and polpharmacy are highly prevalent in 
the hospitalised elderly. The 'S-I-R-E' mnemonic can be used as a memory aid and 
practical framework to guide appropriate prescribing in the elderly.

Copyright: © Singapore Medical Association.

DOI: 10.11622/smedj.2018153
PMCID: PMC6595067
PMID: 30488080 [Indexed for MEDLINE]


10. Biofactors. 2018 Nov;44(6):577-587. doi: 10.1002/biof.1454. Epub 2018 Nov 29.

Curcumin supplementation increases survival and lifespan in Drosophila under 
heat stress conditions.

Chen Y(1), Liu X(1), Jiang C(1), Liu L(2), Ordovas JM(3)(4), Lai CQ(5), Shen 
L(1).

Author information:
(1)Department of Food Science and Nutrition, Zhejiang Key Laboratory for 
Agro-Food Processing, Zhejiang University, Zhejiang, Hangzhou, China.
(2)Department of Statistics, The University of Georgia, Athens, GA, USA.
(3)Nutrition and Genomics Laboratory, JM-USDA Human Nutrition Research Center on 
Aging at Tufts University, Boston, MA, USA.
(4)IMDEA Alimentacion, Madrid, Spain.
(5)USDA ARS, JM-USDA Human Nutrition Research Center on Aging at Tufts 
University, Boston, MA, USA.

Harsh climate induces physiological stress thus compromising organismal 
survival. Our previous studies demonstrated that curcumin (CUR) supplementation 
increased survival of turtle under heat stress (HS). Here, we span this work to 
investigate the survival and lifespan of HS Drosophila fed a diet supplemented 
with CUR. For this purpose, female and male flies were fed basal diet (N) and 
CUR diet (0.2 mg/g), and exposed to three conditions: 25°C and 29°C 
continuously, and 34 °C for 2 h at days 1, 4, and 7, then kept at 25 °C. 
Lifespan analysis showed that, compared to N-25 °C flies, the mean lifespans of 
N-29 °C and N-34 °C flies were decreased significantly by 8.5-15.7% in males, 
and 3.7-7.9% in females. Conversely, in the CUR-supplemented diet, mean 
lifespans of C-29 °C and C-34 °C flies were significantly extended by 8.7-16.4% 
in males, and by 8.9-12.8% in females, compared to that of temperature-matched 
flies fed basal diets. The MDA levels of C-34 °C flies were significantly lower 
than those of N-34 °C flies, indicating CUR reduced oxidative stress caused by 
HS. Furthermore, CUR palliated the increased oxidative stress caused by HS, by 
increasing the expression of SOD1, CAT, and PHGPx and decreasing the expression 
of Hsp70 and Hsp83. Our results indicated that CUR supplementation increases the 
survival rate of Drosophila by enhancing thermal tolerance. © 2018 BioFactors, 
44(6):577-587, 2018.

© 2018 International Union of Biochemistry and Molecular Biology.

DOI: 10.1002/biof.1454
PMID: 30488487 [Indexed for MEDLINE]


11. Scand J Caring Sci. 2019 Jun;33(2):255-265. doi: 10.1111/scs.12627. Epub 2018
 Nov 29.

The caregiving phenomenon and caregiver participation in dementia.

Garcia-Ptacek S(1)(2), Dahlrup B(3), Edlund AK(4), Wijk H(4)(5), Eriksdotter 
M(1)(4)(6).

Author information:
(1)Department of Neurobiology, Care Sciences and Society, Center for Alzheimer 
Research, Division of Clinical Geriatrics, Karolinska Institutet, Huddinge, 
Sweden.
(2)Department of Internal Medicine, Section for Neurology, Södersjukhuset, 
Stockholm, Sweden.
(3)Department of Health Sciences, Division of Geriatric Medicine, Lund 
University, Lund, Sweden.
(4)Aging Theme, SveDem, Svenska Demensregistret, Karolinska University Hospital, 
Huddinge, Sweden.
(5)Institute of Health and Care Science, Gothenburg University, Sahlgrenska 
University Hospital, Sahlgrenska Academy, Gothenburg, Sweden.
(6)Department of Geriatric Medicine/Aging Theme, Karolinska University Hospital, 
Huddinge, Sweden.

BACKGROUND: Dementia presents barriers to the collaboration between individuals 
and the healthcare system. Caregivers perform multiple functions helping 
patients with basic and instrumental activities but also communicating and 
mediating the dyads' needs within the broader social group. Interventions 
focusing on caregivers show that caregiver burden can be reduced, improving 
patient outcomes in a cost-effective way, but the generalisation of these 
findings is limited by several factors such as low participation rates of 
caregivers in studies. There is a global push to increase patient participation 
in health care, but this can be difficult for patients with dementia. Caregiver 
participation has arisen as a substitute, but there is a lack of standardised 
definitions, goals and outcome measurement tools for this participation.
METHODS: In 2015, the Swedish Association of Local Authorities and Regions 
commissioned a study on possibilities of increasing caregiver participation 
within the Swedish Dementia Registry (SveDem). This discussion paper updates and 
adapts that report, aiming to broadly summarise the caregiving phenomenon in 
order to provide a backdrop for clinicians seeking to understand the legal, 
ethical and practical considerations of caregiver participation in dementia. 
Relevant literature on caregiver participation is presented, and its definition, 
extent and practical implementation are discussed.
DISCUSSION: The Swedish legal framework compels care providers to facilitate 
patient and caregiver participation in dementia and provides support to 
caregivers through the local level of government, but further work is needed to 
clarify and define the extension and form that this participation must take in 
clinical practice. Advanced directives are one step in extending patient 
participation to the period of advanced dementia.
CONCLUSION: Little research exists on caregiver participation. There is a need 
to develop a framework for caregiver and patient participation to determine the 
extent, type and form that such participation should take in health care, 
research and quality initiatives pertaining to persons with dementia.

© 2018 The Authors. Scandinavian Journal of Caring Sciences published by John 
Wiley & Sons Ltd on behalf of Nordic College of Caring Science.

DOI: 10.1111/scs.12627
PMCID: PMC7432177
PMID: 30488971 [Indexed for MEDLINE]


12. JAMA Oncol. 2019 Feb 1;5(2):236-242. doi: 10.1001/jamaoncol.2018.5070.

Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic 
Colorectal Cancer.

Sherman SK(1), Lange JJ(2), Dahdaleh FS(1), Rajeev R(3), Gamblin TC(2), Polite 
BN(4), Turaga KK(1).

Author information:
(1)Department of Surgery, University of Chicago, Chicago, Illinois.
(2)Department of Surgery, Medical College of Wisconsin, Milwaukee.
(3)Department of Surgery, University of Texas Rio Grande Valley, Edinburg.
(4)Department of Medicine, University of Chicago, Chicago, Illinois.

IMPORTANCE: Unregulated drug prices increase cancer therapy costs. After 
induction chemotherapy, patients with metastatic colon cancer can receive 
maintenance capecitabine and bevacizumab therapy based on improved 
progression-free survival, but whether this treatment's cost justifies its 
benefits has not been evaluated in the United States.
OBJECTIVE: This study sought to determine the influence of capecitabine and 
bevacizumab drug prices on cost-effectiveness from a Medicare payer's 
perspective.
DESIGN, SETTING, AND PARTICIPANTS: The incremental cost-effectiveness of 
capecitabine and bevacizumab maintenance therapy was determined with a Markov 
model using a quality-of-life penalty based on outcomes data from the CAIRO 
phase 3 randomized clinical trial (RCT), which included 558 adults in the 
Netherlands with unresectable metastatic colorectal cancer who had stable 
disease or better following induction chemotherapy. The outcomes were modeled 
using Markov chains to account for patients who had treatment complications or 
cancer progression. Transition probabilities between patient states were 
determined, and each state's costs were determined using US Medicare data on 
payments for capecitabine and bevacizumab treatment. Deterministic and 
probabilistic sensitivity analyses identified factors affecting 
cost-effectiveness.
MAIN OUTCOMES AND MEASURES: Life-years gained were adjusted using CAIRO3 RCT 
quality-of-life data to determine quality-adjusted life-years (QALYs). The 
primary end point was the incremental cost-effectiveness ratio, representing 
incremental costs per QALY gained using a capecitabine and bevacizumab 
maintenance regimen compared with observation alone.
RESULTS: Markov model estimated survival and complication outcomes closely 
matched those reported in the CAIRO3 RCT, which included 558 adults (n = 197 
women, n = 361 men; median age, 64 and 63 years for patients in the observation 
and maintenance therapy groups, respectively) in the Netherlands with 
unresectable metastatic colorectal cancer who had stable disease or better 
following induction chemotherapy. Incremental costs for a 3-week maintenance 
chemotherapy cycle were $6601 per patient. After 29 model iterations 
corresponding to 60 months of follow-up, mean per-patient costs were $105 239 
for maintenance therapy and $21.10 for observation. Mean QALYs accrued were 1.34 
for maintenance therapy and 1.20 for observation. The incremental 
cost-effectiveness ratio favored maintenance treatment, at an incremental cost 
of $725 601 per QALY. The unadjusted ratio was $438 394 per life-year. 
Sensitivity analyses revealed that cost-effectiveness varied with changes in 
drug costs. To achieve an incremental cost-effectiveness ratio of less than 
$59 039 (median US household income) per unadjusted life-year would require 
capecitabine and bevacizumab drug costs to be reduced from $6173 (current cost) 
to $452 per 3-week chemotherapy cycle.
CONCLUSIONS AND RELEVANCE: Antineoplastic therapy is expensive for payers and 
society. The price of capecitabine and bevacizumab maintenance therapy would 
need to be reduced by 93% to make it cost-effective, a finding useful for policy 
decision making and payment negotiations.

DOI: 10.1001/jamaoncol.2018.5070
PMCID: PMC6440196
PMID: 30489611 [Indexed for MEDLINE]

Conflict of interest statement: Conflict of Interest Disclosures: Dr Turaga 
reports receiving honoraria from Caris Biosciences and Castle Biosciences, 
neither of which has any relationship to the present study. No other disclosures 
reported.


13. Am J Public Health. 2019 Jan;109(1):35-40. doi: 10.2105/AJPH.2018.304747.
Epub  2018 Nov 29.

The Global Burden of Musculoskeletal Pain-Where to From Here?

Blyth FM(1), Briggs AM(1), Schneider CH(1), Hoy DG(1), March LM(1).

Author information:
(1)Fiona M. Blyth is with the Centre for Education and Research on Aging, 
Concord Clinical School, University of Sydney, Sydney, Australia. Andrew M. 
Briggs is with the School of Physiotherapy and Exercise Science, Curtin 
University, Perth, Australia. Carmen Huckel Schneider is with the Menzies Centre 
for Health Policy, Sydney School of Public Health, University of Sydney. Damian 
G. Hoy and Lyn M. March are with the Institute of Bone and Joint Research, 
Northern Clinical School and the Florance and Cope Department of Rheumatology, 
Royal North Shore Hospital, University of Sydney.

To summarize the current understanding of the global burden of musculoskeletal 
pain-related conditions, consider the process of evidence generation and the 
steps to generate global pain estimates, identify key gaps in our understanding, 
and propose an agenda to address these gaps, we performed a narrative review. In 
the 2010 Global Burden of Disease Study (GBD), which broadened the scope of 
musculoskeletal conditions that were included over previous rounds, low back 
pain imposed the highest disability burden of all specific conditions assessed, 
and subsequent GBD reports further reinforce the size of this burden. Over the 
past decade, the GBD has produced compelling evidence of the leading 
contribution of musculoskeletal pain conditions to the global burden of 
disability, but this has not translated into global health policy initiatives. 
However, system- and service-level responses to the disease burden persist 
across high-, middle-, and low-income settings. There is a mismatch between the 
burden of musculoskeletal pain conditions and appropriate health policy response 
and planning internationally that can be addressed with an integrated research 
and policy agenda.

DOI: 10.2105/AJPH.2018.304747
PMCID: PMC6301413
PMID: 30495997 [Indexed for MEDLINE]


14. Lancet. 2018 Nov 10;392(10159):1684-1735. doi: 10.1016/S0140-6736(18)31891-9.
 Epub 2018 Nov 8.

Global, regional, and national age-sex-specific mortality and life expectancy, 
1950-2017: a systematic analysis for the Global Burden of Disease Study 2017.

GBD 2017 Mortality Collaborators.

Collaborators: Dicker D, Nguyen G, Abate D, Abate KH, Abay SM, Abbafati C, 
Abbasi N, Abbastabar H, Abd-Allah F, Abdela J, Abdelalim A, Abdel-Rahman O, Abdi 
A, Abdollahpour I, Abdulkader RS, Abdurahman AA, Abebe HT, Abebe M, Abebe Z, 
Abebo TA, Aboyans V, Abraha HN, Abrham AR, Abu-Raddad LJ, Abu-Rmeileh NM, 
Accrombessi MMK, Acharya P, Adebayo OM, Adedeji IA, Adedoyin RA, Adekanmbi V, 
Adetokunboh OO, Adhena BM, Adhikari TB, Adib MG, Adou AK, Adsuar JC, Afarideh M, 
Afshin A, Agarwal G, Aggarwal R, Aghayan SA, Agrawal S, Agrawal A, Ahmadi M, 
Ahmadi A, Ahmadieh H, Ahmed MLCB, Ahmed S, Ahmed MB, Aichour AN, Aichour I, 
Aichour MTE, Akanda AS, Akbari ME, Akibu M, Akinyemi RO, Akinyemiju T, Akseer N, 
Alahdab F, Al-Aly Z, Alam K, Alebel A, Aleman AV, Alene KA, Al-Eyadhy A, Ali R, 
Alijanzadeh M, Alizadeh-Navaei R, Aljunid SM, Alkerwi A, Alla F, Allebeck P, 
Allen CA, Alonso J, Al-Raddadi RM, Alsharif U, Altirkawi K, Alvis-Guzman N, 
Amare AT, Amini E, Ammar W, Amoako YA, Anber NH, Andrei CL, Androudi S, Animut 
MD, Anjomshoa M, Anlay DZ, Ansari H, Ansariadi A, Ansha MG, Antonio CAT, Appiah 
SCY, Aremu O, Areri HA, Ärnlöv J, Arora M, Artaman A, Aryal KK, Asadi-Lari M, 
Asayesh H, Asfaw ET, Asgedom SW, Assadi R, Ataro Z, Atey TMM, Athari SS, Atique 
S, Atre SR, Atteraya MS, Attia EF, Ausloos M, Avila-Burgos L, Avokpaho EFGA, 
Awasthi A, Awuah B, Ayala Quintanilla BP, Ayele HT, Ayele Y, Ayer R, Ayuk TB, 
Azzopardi PS, Azzopardi-Muscat N, Badali H, Badawi A, Balakrishnan K, Bali AG, 
Banach M, Banstola A, Barac A, Barboza MA, Barquera S, Barrero LH, Basaleem H, 
Bassat Q, Basu A, Basu S, Baune BT, Bazargan-Hejazi S, Bedi N, Beghi E, 
Behzadifar M, Behzadifar M, Béjot Y, Bekele BB, Belachew AB, Belay AG, Belay E, 
Belay SA, Belay YA, Bell ML, Bello AK, Bennett DA, Bensenor IM, Berhane A, 
Berman AE, Bernabe E, Bernstein RS, Bertolacci GJ, Beuran M, Beyranvand T, Bhala 
N, Bhatia E, Bhatt S, Bhattarai S, Bhaumik S, Bhutta ZA, Biadgo B, Bijani A, 
Bikbov B, Bililign N, Bin Sayeed MS, Birlik SM, Birungi C, Bisanzio D, Biswas T, 
Bjørge T, Bleyer A, Basara BB, Bose D, Bosetti C, Boufous S, Bourne R, Brady OJ, 
Bragazzi NL, Brant LC, Brazinova A, Breitborde NJK, Brenner H, Britton G, Brugha 
T, Burke KE, Busse R, Butt ZA, Cahuana-Hurtado L, Callender CSKH, Campos-Nonato 
IR, Campuzano Rincon JC, Cano J, Car M, Cárdenas R, Carreras G, Carrero JJ, 
Carter A, Carvalho F, Castañeda-Orjuela CA, Castillo Rivas J, Castro F, 
Catalá-López F, Çavlin A, Cerin E, Chaiah Y, Champs AP, Chang HY, Chang JC, 
Chattopadhyay A, Chaturvedi P, Chen W, Chiang PP, Chimed-Ochir O, Chin KL, 
Chisumpa VH, Chitheer A, Choi JJ, Christensen H, Christopher DJ, Chung SC, 
Cicuttini FM, Ciobanu LG, Cirillo M, Claro RM, Cohen AJ, Collado-Mateo D, 
Constantin MM, Conti S, Cooper C, Cooper LT, Cortesi PA, Cortinovis M, Cousin E, 
Criqui MH, Cromwell EA, Crowe CS, Crump JA, Cucu A, Cunningham M, Daba AK, 
Dachew BA, Dadi AF, Dandona L, Dandona R, Dang AK, Dargan PI, Daryani A, Das SK, 
Das Gupta R, das Neves J, Dasa TT, Dash AP, Weaver ND, Davitoiu DV, Davletov K, 
Dayama A, Courten B, De la Hoz FP, De Leo D, De Neve JW, Degefa MG, Degenhardt 
L, Degfie TT, Deiparine S, Dellavalle RP, Demoz GT, Demtsu BB, Denova-Gutiérrez 
E, Deribe K, Dervenis N, Des Jarlais DC, Dessie GA, Dey S, Dharmaratne SD, 
Dhimal M, Ding EL, Djalalinia S, Doku DT, Dolan KA, Donnelly CA, Dorsey ER, 
Douwes-Schultz D, Doyle KE, Drake TM, Driscoll TR, Dubey M, Dubljanin E, Duken 
EE, Duncan BB, Duraes AR, Ebrahimi H, Ebrahimpour S, Edessa D, Edvardsson D, 
Eggen AE, El Bcheraoui C, El Sayed Zaki M, Elfaramawi M, El-Khatib Z, Ellingsen 
CL, Elyazar IRF, Enayati A, Endries AYY, Er B, Ermakov SP, Eshrati B, 
Eskandarieh S, Esmaeili R, Esteghamati A, Esteghamati S, Fakhar M, Fakhim H, 
Farag T, Faramarzi M, Fareed M, Farhadi F, Farid TA, Farinha CSES, Farioli A, 
Faro A, Farvid MS, Farzadfar F, Farzaei MH, Fazeli MS, Feigin VL, Feigl AB, 
Feizy F, Fentahun N, Fereshtehnejad SM, Fernandes E, Fernandes JC, Feyissa GT, 
Fijabi DO, Filip I, Finegold S, Fischer F, Flor LS, Foigt NA, Ford JA, Foreman 
KJ, Fornari C, Frank TD, Franklin RC, Fukumoto T, Fuller JE, Fullman N, Fürst T, 
Furtado JM, Futran ND, Galan A, Gallus S, Gambashidze K, Gamkrelidze A, Gankpe 
FG, Garcia-Basteiro AL, Garcia-Gordillo MA, Gebre T, Gebre AK, Gebregergs GB, 
Gebrehiwot TT, Gebremedhin AT, Gelano TF, Gelaw YA, Geleijnse JM, Genova-Maleras 
R, Gessner BD, Getachew S, Gething PW, Gezae KE, Ghadami MR, Ghadimi R, Ghasemi 
Falavarjani K, Ghasemi-Kasman M, Ghiasvand H, Ghimire M, Ghoshal AG, Gill PS, 
Gill TK, Gillum RF, Giussani G, Goenka S, Goli S, Gomez RS, Gomez-Cabrera MC, 
Gómez-Dantés H, Gona PN, Goodridge A, Gopalani SV, Goto A, Goulart AC, Goulart 
BNG, Grada A, Grosso G, Gugnani HC, Guimaraes ALS, Guo Y, Gupta PC, Gupta R, 
Gupta R, Gupta T, Gyawali B, Haagsma JA, Hachinski V, Hafezi-Nejad N, Hagos TB, 
Hailegiyorgis TT, Hailu GB, Haj-Mirzaian A, Haj-Mirzaian A, Hamadeh RR, Hamidi 
S, Handal AJ, Hankey GJ, Harb HL, Harikrishnan S, Haririan H, Haro JM, Hasan M, 
Hassankhani H, Hassen HY, Havmoeller R, Hay RJ, Hay SI, He Y, 
Hedayatizadeh-Omran A, Hegazy MI, Heibati B, Heidari M, Hendrie D, Henok A, 
Henry NJ, Heredia-Pi I, Herteliu C, Heydarpour F, Heydarpour P, Heydarpour S, 
Hibstu DT, Hoek HW, Hole MK, Homaie Rad E, Hoogar P, Horino M, Hosgood HD, 
Hosseini SM, Hosseinzadeh M, Hostiuc S, Hostiuc M, Hotez PJ, Hoy DG, Hsairi M, 
Htet AS, Hu G, Huang JJ, Husseini A, Hussen MM, Hutfless S, Iburg KM, Igumbor 
EU, Ikeda CT, Ilesanmi OS, Iqbal U, Irvani SSN, Isehunwa OO, Islam SMS, Islami 
F, Jahangiry L, Jahanmehr N, Jain R, Jain SK, Jakovljevic M, James SL, 
Javanbakht M, Jayaraman S, Jayatilleke AU, Jee SH, Jeemon P, Jha RP, Jha V, Ji 
JS, Johnson SC, Jonas JB, Joshi A, Jozwiak JJ, Jungari SB, Jürisson M, K M, 
Kabir Z, Kadel R, Kahsay A, Kahssay M, Kalani R, Kapil U, Karami M, Karami Matin 
B, Karch A, Karema C, Karimi N, Karimi SM, Karimi-Sari H, Kasaeian A, Kassa GM, 
Kassa TD, Kassa ZY, Kassebaum NJ, Katibeh M, Katikireddi SV, Kaul A, Kawakami N, 
Kazemeini H, Kazemi Z, Karyani AK, K C P, Kebede S, Keiyoro PN, Kemp GR, Kengne 
AP, Keren A, Kereselidze M, Khader YS, Khafaie MA, Khajavi A, Khalid N, Khalil 
IA, Khan EA, Khan G, Khan MS, Khan MA, Khang YH, Khanna T, Khater MM, Khatony A, 
Khazaie H, Khoja AT, Khosravi A, Khosravi MH, Khubchandani J, Kiadaliri AA, 
Kibret GDD, Kim CI, Kim D, Kim JY, Kim YE, Kimokoti RW, Kinfu Y, Kinra S, Kisa 
A, Kissimova-Skarbek K, Kissoon N, Kivimäki M, Kleber ME, Knibbs LD, Knudsen 
AKS, Kochhar S, Kokubo Y, Kolola T, Kopec JA, Kosek MN, Kosen S, Koul PA, 
Koyanagi A, Kravchenko MA, Krishan K, Krishnaswami S, Kuate Defo B, Kucuk Bicer 
B, Kudom AA, Kuipers EJ, Kulikoff XR, Kumar GA, Kumar M, Kumar P, Kumsa FA, Kutz 
MJ, Lad SD, Lafranconi A, Lal DK, Lalloo R, Lam H, Lami FH, Lan Q, Langan SM, 
Lansingh VC, Lansky S, Larson HJ, Laryea DO, Lassi ZS, Latifi A, Lavados PM, 
Laxmaiah A, Lazarus JV, Lebedev G, Lee PH, Leigh J, Leshargie CT, Leta S, Levi 
M, Li S, Li Y, Li X, Liang J, Liang X, Liben ML, Lim LL, Lim SS, Limenih MA, 
Linn S, Liu S, Liu Y, Lodha R, Logroscino G, Lonsdale C, Lorch SA, Lorkowski S, 
Lotufo PA, Lozano R, Lucas TCD, Lunevicius R, Lyons RA, Ma S, Mabika C, 
Macarayan ERK, Mackay MT, Maddison ER, Maddison R, Madotto F, Magdy Abd El Razek 
H, Magdy Abd El Razek M, Maghavani DP, Majdan M, Majdzadeh R, Majeed A, 
Malekzadeh R, Malik MA, Malta DC, Mamun AA, Manamo WA, Manda AL, Mansournia MA, 
Mantovani LG, Mapoma CC, Marami D, Maravilla JC, Marcenes W, Marina S, 
Martinez-Raga J, Martins SCO, Martins-Melo FR, März W, Marzan MB, 
Mashamba-Thompson TP, Masiye F, Massenburg BB, Maulik PK, Mazidi M, McGrath JJ, 
McKee M, Mehata S, Mehendale SM, Mehndiratta MM, Mehrotra R, Mehta KM, Mehta V, 
Mekonen T, Mekonnen TC, Meles HG, Meles KG, Melese A, Melku M, Memiah PTN, 
Memish ZA, Mendoza W, Mengistu DT, Mengistu G, Mensah GA, Mereta ST, Meretoja A, 
Meretoja TJ, Mestrovic T, Mezgebe HB, Miangotar Y, Miazgowski B, Miazgowski T, 
Miller TR, Mini GK, Mirica A, Mirrakhimov EM, Misganaw AT, Moazen B, Moges NA, 
Mohammad KA, Mohammadi M, Mohammadifard N, Mohammadi-Khanaposhtani M, 
Mohammadnia-Afrouzi M, Mohammed S, Mohammed MA, Mohan V, Mokdad AH, Molokhia M, 
Monasta L, Moradi G, Moradi M, Moradi-Lakeh M, Moradinazar M, Moraga P, Morawska 
L, Moreno Velásquez I, Morgado-da-Costa J, Morrison SD, Mosapour A, Moschos MM, 
Mousavi SM, Muche AA, Muchie KF, Mueller UO, Mukhopadhyay S, Mullany EC, Muller 
K, Murhekar M, Murphy TB, Murthy GVS, Murthy S, Musa J, Musa KI, Mustafa G, 
Muthupandian S, Nachega JB, Nagel G, Naghavi M, Naheed A, Nahvijou A, Naik G, 
Nair S, Najafi F, Nangia V, Nansseu JR, Nascimento BR, Nawaz H, Ncama BP, 
Neamati N, Negoi I, Negoi RI, Neupane S, Newton CRJ, Ngalesoni FN, Ngunjiri JW, 
Nguyen HT, Nguyen HT, Nguyen LH, Nguyen M, Nguyen TH, Ningrum DNA, Nirayo YL, 
Nisar MI, Nixon MR, Nolutshungu N, Nomura S, Norheim OF, Noroozi M, Norrving B, 
Noubiap JJ, Nouri HR, Nourollahpour Shiadeh M, Nowroozi MR, Nsoesie EO, Nyasulu 
PS, Ofori-Asenso R, Ogah OS, Ogbo FA, Oh IH, Okoro A, Oladimeji O, Olagunju AT, 
Olagunju TO, Olivares PR, Olusanya BO, Olusanya JO, Ong SK, Opio JN, Oren E, 
Ortiz JR, Ortiz A, Ota E, Otstavnov SS, Øverland S, Owolabi MO, Oyekale AS, P A 
M, Pacella R, Pakhale S, Pakhare AP, Pana A, Panda BK, Panda-Jonas S, Pandey AR, 
Pandian JD, Parisi A, Park EK, Parry CDH, Parsian H, Patel S, Patle A, Patten 
SB, Patton GC, Paudel D, Pearce N, Peprah EK, Pereira A, Pereira DM, Perez KM, 
Perico N, Pervaiz A, Pesudovs K, Petri WA, Petzold M, Phillips MR, Pigott DM, 
Pillay JD, Pirsaheb M, Pishgar F, Plass D, Polinder S, Pond CD, Popova S, Postma 
MJ, Pourmalek F, Pourshams A, Poustchi H, Prabhakaran D, Prakash V, Prakash S, 
Prasad N, Qorbani M, Quistberg DA, Radfar A, Rafay A, Rafiei A, Rahim F, Rahimi 
K, Rahimi-Movaghar A, Rahimi-Movaghar V, Rahman M, Rahman MHU, Rahman MA, Rahman 
SU, Rai RK, Rajati F, Rajsic S, Raju SB, Ram U, Ranabhat CL, Ranjan P, Ranta A, 
Rasella D, Rawaf DL, Rawaf S, Ray SE, Razo-García C, Rego MAS, Rehm J, Reiner 
RC, Reinig N, Reis C, Remuzzi G, Renzaho AMN, Resnikoff S, Rezaei S, Rezaeian S, 
Rezai MS, Riahi SM, Ribeiro ALP, Riojas H, Rios-Blancas MJ, Roba KT, Robinson 
SR, Roever L, Ronfani L, Roshandel G, Roshchin DO, Rostami A, Rothenbacher D, 
Rubagotti E, Ruhago GM, Saadat S, Sabde YD, Sachdev PS, Saddik B, Sadeghi E, 
Moghaddam SS, Safari H, Safari Y, Safari-Faramani R, Safdarian M, Safi S, Safiri 
S, Sagar R, Sahebkar A, Sahraian MA, Sajadi HS, Salahshoor M, Salam N, Salama 
JS, Salamati P, Saldanha RF, Salimi Y, Salimzadeh H, Salz I, Sambala EZ, Samy 
AM, Sanabria J, Sanchez-Niño MD, Santos IS, Santos JV, Santric Milicevic MM, Sao 
Jose BP, Sardana M, Sarker AR, Sarrafzadegan N, Sartorius B, Sarvi S, Sathian B, 
Satpathy M, Savic M, Sawant AR, Sawhney M, Saxena S, Sayyah M, Scaria V, 
Schaeffner E, Schelonka K, Schmidt MI, Schneider IJC, Schöttker B, Schutte AE, 
Schwebel DC, Schwendicke F, Scott JG, Sekerija M, Sepanlou SG, Serván-Mori E, 
Shabaninejad H, Shackelford KA, Shafieesabet A, Shaheen AA, Shaikh MA, Shakir 
RA, Shams-Beyranvand M, Shamsi M, Shamsizadeh M, Sharafi H, Sharafi K, Sharif M, 
Sharif-Alhoseini M, Sharma M, Sharma J, Sharma R, She J, Sheikh A, Sheth KN, Shi 
P, Shibuya K, Shifa GT, Shiferaw MS, Shigematsu M, Shiri R, Shirkoohi R, Shiue 
I, Shokraneh F, Shrime MG, Shukla SR, Si S, Siabani S, Siddiqi TJ, Sigfusdottir 
ID, Sigurvinsdottir R, Silpakit N, Silva DAS, Silva JP, Silveira DGA, Singam 
NSV, Singh JA, Singh V, Sinha AP, Sinha DN, Sitas F, Skirbekk V, Sliwa K, Soares 
Filho AM, Sobaih BH, Sobhani S, Soofi M, Soriano JB, Soyiri IN, Sposato LA, 
Sreeramareddy CT, Srinivasan V, Srivastava RK, Starodubov VI, Stathopoulou V, 
Steel N, Stein DJ, Steiner C, Stewart LG, Stokes MA, Sudaryanto A, Sufiyan MB, 
Sulo G, Sunguya BF, Sur PJ, Sutradhar I, Sykes BL, Sylaja PN, Sylte DO, Szoeke 
CEI, Tabarés-Seisdedos R, Tabuchi T, Tadakamadla SK, Takahashi K, Tandon N, 
Tassew AA, Tassew SG, Tavakkoli M, Taveira N, Tawye NY, Tehrani-Banihashemi A, 
Tekalign TG, Tekle MG, Temesgen H, Temsah MH, Temsah O, Terkawi AS, Teshale MY, 
Tessema B, Teweldemedhin M, Thakur JS, Thankappan KR, Thirunavukkarasu S, Thomas 
LA, Thomas N, Thrift AG, Tilahun B, To QG, Tobe-Gai R, Tonelli M, Topor-Madry R, 
Topouzis F, Torre AE, Tortajada-Girbés M, Tovani-Palone MR, Towbin JA, Tran BX, 
Tran KB, Tripathi S, Tripathy SP, Truelsen TC, Truong NT, Tsadik AG, Tsilimparis 
N, Tudor Car L, Tuzcu EM, Tyrovolas S, Ukwaja KN, Ullah I, Usman MS, Uthman OA, 
Uzun SB, Vaduganathan M, Vaezi A, Vaidya G, Valdez PR, Varavikova E, Varughese 
S, Vasankari TJ, Vasconcelos AMN, Venketasubramanian N, Vidavalur R, Villafaina 
S, Violante FS, Vladimirov SK, Vlassov V, Vollset SE, Vos T, Vosoughi K, Vujcic 
IS, Wagner GR, Wagnew FWS, Waheed Y, Wang Y, Wang YP, Wassie MM, Weiderpass E, 
Weintraub RG, Weiss DJ, Weiss J, Weldegebreal F, Weldegwergs KG, Werdecker A, 
Westerman R, Whiteford HA, Widecka J, Widecka K, Wijeratne T, Winkler AS, 
Wiysonge CS, Wolfe CDA, Wondemagegn SA, Wu S, Wyper GMA, Xu G, Yadav R, Yakob B, 
Yamada T, Yan LL, Yano Y, Yaseri M, Yasin YJ, Ye P, Yearwood JA, Yentür GK, 
Yeshaneh A, Yimer EM, Yip P, Yisma E, Yonemoto N, Yoon SJ, York HW, Yotebieng M, 
Younis MZ, Yousefifard M, Yu C, Zachariah G, Zadnik V, Zafar S, Zaidi Z, Zaman 
SB, Zamani M, Zare Z, Zeeb H, Zeleke MM, Zenebe ZM, Zerfu TA, Zhang K, Zhang X, 
Zhou M, Zhu J, Zodpey S, Zucker I, Zuhlke LJJ, Lopez AD, Gakidou E, Murray CJL.

Erratum in
    Lancet. 2019 Jun 22;393(10190):e44.

BACKGROUND: Assessments of age-specific mortality and life expectancy have been 
done by the UN Population Division, Department of Economics and Social Affairs 
(UNPOP), the United States Census Bureau, WHO, and as part of previous 
iterations of the Global Burden of Diseases, Injuries, and Risk Factors Study 
(GBD). Previous iterations of the GBD used population estimates from UNPOP, 
which were not derived in a way that was internally consistent with the 
estimates of the numbers of deaths in the GBD. The present iteration of the GBD, 
GBD 2017, improves on previous assessments and provides timely estimates of the 
mortality experience of populations globally.
METHODS: The GBD uses all available data to produce estimates of mortality rates 
between 1950 and 2017 for 23 age groups, both sexes, and 918 locations, 
including 195 countries and territories and subnational locations for 16 
countries. Data used include vital registration systems, sample registration 
systems, household surveys (complete birth histories, summary birth histories, 
sibling histories), censuses (summary birth histories, household deaths), and 
Demographic Surveillance Sites. In total, this analysis used 8259 data sources. 
Estimates of the probability of death between birth and the age of 5 years and 
between ages 15 and 60 years are generated and then input into a model life 
table system to produce complete life tables for all locations and years. Fatal 
discontinuities and mortality due to HIV/AIDS are analysed separately and then 
incorporated into the estimation. We analyse the relationship between 
age-specific mortality and development status using the Socio-demographic Index, 
a composite measure based on fertility under the age of 25 years, education, and 
income. There are four main methodological improvements in GBD 2017 compared 
with GBD 2016: 622 additional data sources have been incorporated; new estimates 
of population, generated by the GBD study, are used; statistical methods used in 
different components of the analysis have been further standardised and 
improved; and the analysis has been extended backwards in time by two decades to 
start in 1950.
FINDINGS: Globally, 18·7% (95% uncertainty interval 18·4-19·0) of deaths were 
registered in 1950 and that proportion has been steadily increasing since, with 
58·8% (58·2-59·3) of all deaths being registered in 2015. At the global level, 
between 1950 and 2017, life expectancy increased from 48·1 years (46·5-49·6) to 
70·5 years (70·1-70·8) for men and from 52·9 years (51·7-54·0) to 75·6 years 
(75·3-75·9) for women. Despite this overall progress, there remains substantial 
variation in life expectancy at birth in 2017, which ranges from 49·1 years 
(46·5-51·7) for men in the Central African Republic to 87·6 years (86·9-88·1) 
among women in Singapore. The greatest progress across age groups was for 
children younger than 5 years; under-5 mortality dropped from 216·0 deaths 
(196·3-238·1) per 1000 livebirths in 1950 to 38·9 deaths (35·6-42·83) per 1000 
livebirths in 2017, with huge reductions across countries. Nevertheless, there 
were still 5·4 million (5·2-5·6) deaths among children younger than 5 years in 
the world in 2017. Progress has been less pronounced and more variable for 
adults, especially for adult males, who had stagnant or increasing mortality 
rates in several countries. The gap between male and female life expectancy 
between 1950 and 2017, while relatively stable at the global level, shows 
distinctive patterns across super-regions and has consistently been the largest 
in central Europe, eastern Europe, and central Asia, and smallest in south Asia. 
Performance was also variable across countries and time in observed mortality 
rates compared with those expected on the basis of development.
INTERPRETATION: This analysis of age-sex-specific mortality shows that there are 
remarkably complex patterns in population mortality across countries. The 
findings of this study highlight global successes, such as the large decline in 
under-5 mortality, which reflects significant local, national, and global 
commitment and investment over several decades. However, they also bring 
attention to mortality patterns that are a cause for concern, particularly among 
adult men and, to a lesser extent, women, whose mortality rates have stagnated 
in many countries over the time period of this study, and in some cases are 
increasing.
FUNDING: Bill & Melinda Gates Foundation.

Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open 
Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All 
rights reserved.

DOI: 10.1016/S0140-6736(18)31891-9
PMCID: PMC6227504
PMID: 30496102 [Indexed for MEDLINE]


15. Lancet. 2018 Nov 10;392(10159):1736-1788. doi: 10.1016/S0140-6736(18)32203-7.
 Epub 2018 Nov 8.

Global, regional, and national age-sex-specific mortality for 282 causes of 
death in 195 countries and territories, 1980-2017: a systematic analysis for the 
Global Burden of Disease Study 2017.

GBD 2017 Causes of Death Collaborators.

Collaborators: Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, 
Abbastabar H, Abd-Allah F, Abdela J, Abdelalim A, Abdollahpour I, Abdulkader RS, 
Abebe HT, Abebe M, Abebe Z, Abejie AN, Abera SF, Abil OZ, Abraha HN, Abrham AR, 
Abu-Raddad LJ, Accrombessi MMK, Acharya D, Adamu AA, Adebayo OM, Adedoyin RA, 
Adekanmbi V, Adetokunboh OO, Adhena BM, Adib MG, Admasie A, Afshin A, Agarwal G, 
Agesa KM, Agrawal A, Agrawal S, Ahmadi A, Ahmadi M, Ahmed MB, Ahmed S, Aichour 
AN, Aichour I, Aichour MTE, Akbari ME, Akinyemi RO, Akseer N, Al-Aly Z, 
Al-Eyadhy A, Al-Raddadi RM, Alahdab F, Alam K, Alam T, Alebel A, Alene KA, 
Alijanzadeh M, Alizadeh-Navaei R, Aljunid SM, Alkerwi A, Alla F, Allebeck P, 
Alonso J, Altirkawi K, Alvis-Guzman N, Amare AT, Aminde LN, Amini E, Ammar W, 
Amoako YA, Anber NH, Andrei CL, Androudi S, Animut MD, Anjomshoa M, Ansari H, 
Ansha MG, Antonio CAT, Anwari P, Aremu O, Ärnlöv J, Arora A, Arora M, Artaman A, 
Aryal KK, Asayesh H, Asfaw ET, Ataro Z, Atique S, Atre SR, Ausloos M, Avokpaho 
EFGA, Awasthi A, Quintanilla BPA, Ayele Y, Ayer R, Azzopardi PS, Babazadeh A, 
Bacha U, Badali H, Badawi A, Bali AG, Ballesteros KE, Banach M, Banerjee K, 
Bannick MS, Banoub JAM, Barboza MA, Barker-Collo SL, Bärnighausen TW, Barquera 
S, Barrero LH, Bassat Q, Basu S, Baune BT, Baynes HW, Bazargan-Hejazi S, Bedi N, 
Beghi E, Behzadifar M, Behzadifar M, Béjot Y, Bekele BB, Belachew AB, Belay E, 
Belay YA, Bell ML, Bello AK, Bennett DA, Bensenor IM, Berman AE, Bernabe E, 
Bernstein RS, Bertolacci GJ, Beuran M, Beyranvand T, Bhalla A, Bhattarai S, 
Bhaumik S, Bhutta ZA, Biadgo B, Biehl MH, Bijani A, Bikbov B, Bilano V, Bililign 
N, Bin Sayeed MS, Bisanzio D, Biswas T, Blacker BF, Basara BB, Borschmann R, 
Bosetti C, Bozorgmehr K, Brady OJ, Brant LC, Brayne C, Brazinova A, Breitborde 
NJK, Brenner H, Briant PS, Britton G, Brugha T, Busse R, Butt ZA, Callender 
CSKH, Campos-Nonato IR, Campuzano Rincon JC, Cano J, Car M, Cárdenas R, Carreras 
G, Carrero JJ, Carter A, Carvalho F, Castañeda-Orjuela CA, Castillo Rivas J, 
Castle CD, Castro C, Castro F, Catalá-López F, Cerin E, Chaiah Y, Chang JC, 
Charlson FJ, Chaturvedi P, Chiang PP, Chimed-Ochir O, Chisumpa VH, Chitheer A, 
Chowdhury R, Christensen H, Christopher DJ, Chung SC, Cicuttini FM, Ciobanu LG, 
Cirillo M, Cohen AJ, Cooper LT, Cortesi PA, Cortinovis M, Cousin E, Cowie BC, 
Criqui MH, Cromwell EA, Crowe CS, Crump JA, Cunningham M, Daba AK, Dadi AF, 
Dandona L, Dandona R, Dang AK, Dargan PI, Daryani A, Das SK, Gupta RD, Neves JD, 
Dasa TT, Dash AP, Davis AC, Davis Weaver N, Davitoiu DV, Davletov K, De La Hoz 
FP, De Neve JW, Degefa MG, Degenhardt L, Degfie TT, Deiparine S, Demoz GT, 
Demtsu BB, Denova-Gutiérrez E, Deribe K, Dervenis N, Des Jarlais DC, Dessie GA, 
Dey S, Dharmaratne SD, Dicker D, Dinberu MT, Ding EL, Dirac MA, Djalalinia S, 
Dokova K, Doku DT, Donnelly CA, Dorsey ER, Doshi PP, Douwes-Schultz D, Doyle KE, 
Driscoll TR, Dubey M, Dubljanin E, Duken EE, Duncan BB, Duraes AR, Ebrahimi H, 
Ebrahimpour S, Edessa D, Edvardsson D, Eggen AE, El Bcheraoui C, El Sayed Zaki 
M, El-Khatib Z, Elkout H, Ellingsen CL, Endres M, Endries AY, Er B, Erskine HE, 
Eshrati B, Eskandarieh S, Esmaeili R, Esteghamati A, Fakhar M, Fakhim H, 
Faramarzi M, Fareed M, Farhadi F, Farinha CSES, Faro A, Farvid MS, Farzadfar F, 
Farzaei MH, Feigin VL, Feigl AB, Fentahun N, Fereshtehnejad SM, Fernandes E, 
Fernandes JC, Ferrari AJ, Feyissa GT, Filip I, Finegold S, Fischer F, 
Fitzmaurice C, Foigt NA, Foreman KJ, Fornari C, Frank TD, Fukumoto T, Fuller JE, 
Fullman N, Fürst T, Furtado JM, Futran ND, Gallus S, Garcia-Basteiro AL, 
Garcia-Gordillo MA, Gardner WM, Gebre AK, Gebrehiwot TT, Gebremedhin AT, 
Gebremichael B, Gebremichael TG, Gelano TF, Geleijnse JM, Genova-Maleras R, 
Geramo YCD, Gething PW, Gezae KE, Ghadami MR, Ghadimi R, Ghasemi Falavarjani K, 
Ghasemi-Kasman M, Ghimire M, Gibney KB, Gill PS, Gill TK, Gillum RF, Ginawi IA, 
Giroud M, Giussani G, Goenka S, Goldberg EM, Goli S, Gómez-Dantés H, Gona PN, 
Gopalani SV, Gorman TM, Goto A, Goulart AC, Gnedovskaya EV, Grada A, Grosso G, 
Gugnani HC, Guimaraes ALS, Guo Y, Gupta PC, Gupta R, Gupta R, Gupta T, Gutiérrez 
RA, Gyawali B, Haagsma JA, Hafezi-Nejad N, Hagos TB, Hailegiyorgis TT, Hailu GB, 
Haj-Mirzaian A, Haj-Mirzaian A, Hamadeh RR, Hamidi S, Handal AJ, Hankey GJ, Harb 
HL, Harikrishnan S, Haro JM, Hasan M, Hassankhani H, Hassen HY, Havmoeller R, 
Hay RJ, Hay SI, He Y, Hedayatizadeh-Omran A, Hegazy MI, Heibati B, Heidari M, 
Hendrie D, Henok A, Henry NJ, Herteliu C, Heydarpour F, Heydarpour P, Heydarpour 
S, Hibstu DT, Hoek HW, Hole MK, Homaie Rad E, Hoogar P, Hosgood HD, Hosseini SM, 
Hosseinzadeh M, Hostiuc M, Hostiuc S, Hotez PJ, Hoy DG, Hsiao T, Hu G, Huang JJ, 
Husseini A, Hussen MM, Hutfless S, Idrisov B, Ilesanmi OS, Iqbal U, Irvani SSN, 
Irvine CMS, Islam N, Islam SMS, Islami F, Jacobsen KH, Jahangiry L, Jahanmehr N, 
Jain SK, Jakovljevic M, Jalu MT, James SL, Javanbakht M, Jayatilleke AU, Jeemon 
P, Jenkins KJ, Jha RP, Jha V, Johnson CO, Johnson SC, Jonas JB, Joshi A, Jozwiak 
JJ, Jungari SB, Jürisson M, Kabir Z, Kadel R, Kahsay A, Kalani R, Karami M, 
Karami Matin B, Karch A, Karema C, Karimi-Sari H, Kasaeian A, Kassa DH, Kassa 
GM, Kassa TD, Kassebaum NJ, Katikireddi SV, Kaul A, Kazemi Z, Karyani AK, Kazi 
DS, Kefale AT, Keiyoro PN, Kemp GR, Kengne AP, Keren A, Kesavachandran CN, 
Khader YS, Khafaei B, Khafaie MA, Khajavi A, Khalid N, Khalil IA, Khan EA, Khan 
MS, Khan MA, Khang YH, Khater MM, Khoja AT, Khosravi A, Khosravi MH, 
Khubchandani J, Kiadaliri AA, Kibret GD, Kidanemariam ZT, Kiirithio DN, Kim D, 
Kim YE, Kim YJ, Kimokoti RW, Kinfu Y, Kisa A, Kissimova-Skarbek K, Kivimäki M, 
Knudsen AKS, Kocarnik JM, Kochhar S, Kokubo Y, Kolola T, Kopec JA, Koul PA, 
Koyanagi A, Kravchenko MA, Krishan K, Kuate Defo B, Kucuk Bicer B, Kumar GA, 
Kumar M, Kumar P, Kutz MJ, Kuzin I, Kyu HH, Lad DP, Lad SD, Lafranconi A, Lal 
DK, Lalloo R, Lallukka T, Lam JO, Lami FH, Lansingh VC, Lansky S, Larson HJ, 
Latifi A, Lau KM, Lazarus JV, Lebedev G, Lee PH, Leigh J, Leili M, Leshargie CT, 
Li S, Li Y, Liang J, Lim LL, Lim SS, Limenih MA, Linn S, Liu S, Liu Y, Lodha R, 
Lonsdale C, Lopez AD, Lorkowski S, Lotufo PA, Lozano R, Lunevicius R, Ma S, 
Macarayan ERK, Mackay MT, MacLachlan JH, Maddison ER, Madotto F, Magdy Abd El 
Razek H, Magdy Abd El Razek M, Maghavani DP, Majdan M, Majdzadeh R, Majeed A, 
Malekzadeh R, Malta DC, Manda AL, Mandarano-Filho LG, Manguerra H, Mansournia 
MA, Mapoma CC, Marami D, Maravilla JC, Marcenes W, Marczak L, Marks A, Marks GB, 
Martinez G, Martins-Melo FR, Martopullo I, März W, Marzan MB, Masci JR, 
Massenburg BB, Mathur MR, Mathur P, Matzopoulos R, Maulik PK, Mazidi M, 
McAlinden C, McGrath JJ, McKee M, McMahon BJ, Mehata S, Mehndiratta MM, Mehrotra 
R, Mehta KM, Mehta V, Mekonnen TC, Melese A, Melku M, Memiah PTN, Memish ZA, 
Mendoza W, Mengistu DT, Mengistu G, Mensah GA, Mereta ST, Meretoja A, Meretoja 
TJ, Mestrovic T, Mezgebe HB, Miazgowski B, Miazgowski T, Millear AI, Miller TR, 
Miller-Petrie MK, Mini GK, Mirabi P, Mirarefin M, Mirica A, Mirrakhimov EM, 
Misganaw AT, Mitiku H, Moazen B, Mohammad KA, Mohammadi M, Mohammadifard N, 
Mohammed MA, Mohammed S, Mohan V, Mokdad AH, Molokhia M, Monasta L, Moradi G, 
Moradi-Lakeh M, Moradinazar M, Moraga P, Morawska L, Moreno Velásquez I, 
Morgado-Da-Costa J, Morrison SD, Moschos MM, Mouodi S, Mousavi SM, Muchie KF, 
Mueller UO, Mukhopadhyay S, Muller K, Mumford JE, Musa J, Musa KI, Mustafa G, 
Muthupandian S, Nachega JB, Nagel G, Naheed A, Nahvijou A, Naik G, Nair S, 
Najafi F, Naldi L, Nam HS, Nangia V, Nansseu JR, Nascimento BR, Natarajan G, 
Neamati N, Negoi I, Negoi RI, Neupane S, Newton CRJ, Ngalesoni FN, Ngunjiri JW, 
Nguyen AQ, Nguyen G, Nguyen HT, Nguyen HT, Nguyen LH, Nguyen M, Nguyen TH, 
Nichols E, Ningrum DNA, Nirayo YL, Nixon MR, Nolutshungu N, Nomura S, Norheim 
OF, Noroozi M, Norrving B, Noubiap JJ, Nouri HR, Nourollahpour Shiadeh M, 
Nowroozi MR, Nyasulu PS, Odell CM, Ofori-Asenso R, Ogbo FA, Oh IH, Oladimeji O, 
Olagunju AT, Olivares PR, Olsen HE, Olusanya BO, Olusanya JO, Ong KL, Ong SKS, 
Oren E, Orpana HM, Ortiz A, Ortiz JR, Otstavnov SS, Øverland S, Owolabi MO, 
Özdemir R, P A M, Pacella R, Pakhale S, Pakhare AP, Pakpour AH, Pana A, 
Panda-Jonas S, Pandian JD, Parisi A, Park EK, Parry CDH, Parsian H, Patel S, 
Pati S, Patton GC, Paturi VR, Paulson KR, Pereira A, Pereira DM, Perico N, 
Pesudovs K, Petzold M, Phillips MR, Piel FB, Pigott DM, Pillay JD, Pirsaheb M, 
Pishgar F, Polinder S, Postma MJ, Pourshams A, Poustchi H, Pujar A, Prakash S, 
Prasad N, Purcell CA, Qorbani M, Quintana H, Quistberg DA, Rade KW, Radfar A, 
Rafay A, Rafiei A, Rahim F, Rahimi K, Rahimi-Movaghar A, Rahman M, Rahman MHU, 
Rahman MA, Rai RK, Rajsic S, Ram U, Ranabhat CL, Ranjan P, Rao PC, Rawaf DL, 
Rawaf S, Razo-García C, Reddy KS, Reiner RC, Reitsma MB, Remuzzi G, Renzaho AMN, 
Resnikoff S, Rezaei S, Rezaeian S, Rezai MS, Riahi SM, Ribeiro ALP, Rios-Blancas 
MJ, Roba KT, Roberts NLS, Robinson SR, Roever L, Ronfani L, Roshandel G, Rostami 
A, Rothenbacher D, Roy A, Rubagotti E, Sachdev PS, Saddik B, Sadeghi E, Safari 
H, Safdarian M, Safi S, Safiri S, Sagar R, Sahebkar A, Sahraian MA, Salam N, 
Salama JS, Salamati P, Saldanha RF, Saleem Z, Salimi Y, Salvi SS, Salz I, 
Sambala EZ, Samy AM, Sanabria J, Sanchez-Niño MD, Santomauro DF, Santos IS, 
Santos JV, Milicevic MMS, Sao Jose BP, Sarker AR, Sarmiento-Suárez R, 
Sarrafzadegan N, Sartorius B, Sarvi S, Sathian B, Satpathy M, Sawant AR, Sawhney 
M, Saxena S, Sayyah M, Schaeffner E, Schmidt MI, Schneider IJC, Schöttker B, 
Schutte AE, Schwebel DC, Schwendicke F, Scott JG, Sekerija M, Sepanlou SG, 
Serván-Mori E, Seyedmousavi S, Shabaninejad H, Shackelford KA, Shafieesabet A, 
Shahbazi M, Shaheen AA, Shaikh MA, Shams-Beyranvand M, Shamsi M, Shamsizadeh M, 
Sharafi K, Sharif M, Sharif-Alhoseini M, Sharma R, She J, Sheikh A, Shi P, 
Shiferaw MS, Shigematsu M, Shiri R, Shirkoohi R, Shiue I, Shokraneh F, Shrime 
MG, Si S, Siabani S, Siddiqi TJ, Sigfusdottir ID, Sigurvinsdottir R, Silberberg 
DH, Silva DAS, Silva JP, Silva NTD, Silveira DGA, Singh JA, Singh NP, Singh PK, 
Singh V, Sinha DN, Sliwa K, Smith M, Sobaih BH, Sobhani S, Sobngwi E, Soneji SS, 
Soofi M, Sorensen RJD, Soriano JB, Soyiri IN, Sposato LA, Sreeramareddy CT, 
Srinivasan V, Stanaway JD, Starodubov VI, Stathopoulou V, Stein DJ, Steiner C, 
Stewart LG, Stokes MA, Subart ML, Sudaryanto A, Sufiyan MB, Sur PJ, Sutradhar I, 
Sykes BL, Sylaja PN, Sylte DO, Szoeke CEI, Tabarés-Seisdedos R, Tabuchi T, 
Tadakamadla SK, Takahashi K, Tandon N, Tassew SG, Taveira N, Tehrani-Banihashemi 
A, Tekalign TG, Tekle MG, Temsah MH, Temsah O, Terkawi AS, Teshale MY, Tessema 
B, Tessema GA, Thankappan KR, Thirunavukkarasu S, Thomas N, Thrift AG, Thurston 
GD, Tilahun B, To QG, Tobe-Gai R, Tonelli M, Topor-Madry R, Torre AE, 
Tortajada-Girbés M, Touvier M, Tovani-Palone MR, Tran BX, Tran KB, Tripathi S, 
Troeger CE, Truelsen TC, Truong NT, Tsadik AG, Tsoi D, Tudor Car L, Tuzcu EM, 
Tyrovolas S, Ukwaja KN, Ullah I, Undurraga EA, Updike RL, Usman MS, Uthman OA, 
Uzun SB, Vaduganathan M, Vaezi A, Vaidya G, Valdez PR, Varavikova E, Vasankari 
TJ, Venketasubramanian N, Villafaina S, Violante FS, Vladimirov SK, Vlassov V, 
Vollset SE, Vos T, Wagner GR, Wagnew FS, Waheed Y, Wallin MT, Walson JL, Wang Y, 
Wang YP, Wassie MM, Weiderpass E, Weintraub RG, Weldegebreal F, Weldegwergs KG, 
Werdecker A, Werkneh AA, West TE, Westerman R, Whiteford HA, Widecka J, Wilner 
LB, Wilson S, Winkler AS, Wiysonge CS, Wolfe CDA, Wu S, Wu YC, Wyper GMA, Xavier 
D, Xu G, Yadgir S, Yadollahpour A, Yahyazadeh Jabbari SH, Yakob B, Yan LL, Yano 
Y, Yaseri M, Yasin YJ, Yentür GK, Yeshaneh A, Yimer EM, Yip P, Yirsaw BD, Yisma 
E, Yonemoto N, Yonga G, Yoon SJ, Yotebieng M, Younis MZ, Yousefifard M, Yu C, 
Zadnik V, Zaidi Z, Zaman SB, Zamani M, Zare Z, Zeleke AJ, Zenebe ZM, Zhang AL, 
Zhang K, Zhou M, Zodpey S, Zuhlke LJ, Naghavi M, Murray CJL.

Erratum in
    Lancet. 2019 Jun 22;393(10190):e44.
    Lancet. 2018 Nov 17;392(10160):2170.

BACKGROUND: Global development goals increasingly rely on country-specific 
estimates for benchmarking a nation's progress. To meet this need, the Global 
Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 estimated 
global, regional, national, and, for selected locations, subnational 
cause-specific mortality beginning in the year 1980. Here we report an update to 
that study, making use of newly available data and improved methods. GBD 2017 
provides a comprehensive assessment of cause-specific mortality for 282 causes 
in 195 countries and territories from 1980 to 2017.
METHODS: The causes of death database is composed of vital registration (VR), 
verbal autopsy (VA), registry, survey, police, and surveillance data. GBD 2017 
added ten VA studies, 127 country-years of VR data, 502 cancer-registry 
country-years, and an additional surveillance country-year. Expansions of the 
GBD cause of death hierarchy resulted in 18 additional causes estimated for GBD 
2017. Newly available data led to subnational estimates for five additional 
countries-Ethiopia, Iran, New Zealand, Norway, and Russia. Deaths assigned 
International Classification of Diseases (ICD) codes for non-specific, 
implausible, or intermediate causes of death were reassigned to underlying 
causes by redistribution algorithms that were incorporated into uncertainty 
estimation. We used statistical modelling tools developed for GBD, including the 
Cause of Death Ensemble model (CODEm), to generate cause fractions and 
cause-specific death rates for each location, year, age, and sex. Instead of 
using UN estimates as in previous versions, GBD 2017 independently estimated 
population size and fertility rate for all locations. Years of life lost (YLLs) 
were then calculated as the sum of each death multiplied by the standard life 
expectancy at each age. All rates reported here are age-standardised.
FINDINGS: At the broadest grouping of causes of death (Level 1), 
non-communicable diseases (NCDs) comprised the greatest fraction of deaths, 
contributing to 73·4% (95% uncertainty interval [UI] 72·5-74·1) of total deaths 
in 2017, while communicable, maternal, neonatal, and nutritional (CMNN) causes 
accounted for 18·6% (17·9-19·6), and injuries 8·0% (7·7-8·2). Total numbers of 
deaths from NCD causes increased from 2007 to 2017 by 22·7% (21·5-23·9), 
representing an additional 7·61 million (7·20-8·01) deaths estimated in 2017 
versus 2007. The death rate from NCDs decreased globally by 7·9% (7·0-8·8). The 
number of deaths for CMNN causes decreased by 22·2% (20·0-24·0) and the death 
rate by 31·8% (30·1-33·3). Total deaths from injuries increased by 2·3% 
(0·5-4·0) between 2007 and 2017, and the death rate from injuries decreased by 
13·7% (12·2-15·1) to 57·9 deaths (55·9-59·2) per 100 000 in 2017. Deaths from 
substance use disorders also increased, rising from 284 000 deaths 
(268 000-289 000) globally in 2007 to 352 000 (334 000-363 000) in 2017. Between 
2007 and 2017, total deaths from conflict and terrorism increased by 118·0% 
(88·8-148·6). A greater reduction in total deaths and death rates was observed 
for some CMNN causes among children younger than 5 years than for older adults, 
such as a 36·4% (32·2-40·6) reduction in deaths from lower respiratory 
infections for children younger than 5 years compared with a 33·6% (31·2-36·1) 
increase in adults older than 70 years. Globally, the number of deaths was 
greater for men than for women at most ages in 2017, except at ages older than 
85 years. Trends in global YLLs reflect an epidemiological transition, with 
decreases in total YLLs from enteric infections, respiratory infections and 
tuberculosis, and maternal and neonatal disorders between 1990 and 2017; these 
were generally greater in magnitude at the lowest levels of the 
Socio-demographic Index (SDI). At the same time, there were large increases in 
YLLs from neoplasms and cardiovascular diseases. YLL rates decreased across the 
five leading Level 2 causes in all SDI quintiles. The leading causes of YLLs in 
1990-neonatal disorders, lower respiratory infections, and diarrhoeal 
diseases-were ranked second, fourth, and fifth, in 2017. Meanwhile, estimated 
YLLs increased for ischaemic heart disease (ranked first in 2017) and stroke 
(ranked third), even though YLL rates decreased. Population growth contributed 
to increased total deaths across the 20 leading Level 2 causes of mortality 
between 2007 and 2017. Decreases in the cause-specific mortality rate reduced 
the effect of population growth for all but three causes: substance use 
disorders, neurological disorders, and skin and subcutaneous diseases.
INTERPRETATION: Improvements in global health have been unevenly distributed 
among populations. Deaths due to injuries, substance use disorders, armed 
conflict and terrorism, neoplasms, and cardiovascular disease are expanding 
threats to global health. For causes of death such as lower respiratory and 
enteric infections, more rapid progress occurred for children than for the 
oldest adults, and there is continuing disparity in mortality rates by sex 
across age groups. Reductions in the death rate of some common diseases are 
themselves slowing or have ceased, primarily for NCDs, and the death rate for 
selected causes has increased in the past decade.
FUNDING: Bill & Melinda Gates Foundation.

Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open 
Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All 
rights reserved.

DOI: 10.1016/S0140-6736(18)32203-7
PMCID: PMC6227606
PMID: 30496103 [Indexed for MEDLINE]


16. Lancet. 2018 Nov 10;392(10159):1789-1858. doi: 10.1016/S0140-6736(18)32279-7.
 Epub 2018 Nov 8.

Global, regional, and national incidence, prevalence, and years lived with 
disability for 354 diseases and injuries for 195 countries and territories, 
1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

GBD 2017 Disease and Injury Incidence and Prevalence Collaborators.

Collaborators: James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, 
Abbastabar H, Abd-Allah F, Abdela J, Abdelalim A, Abdollahpour I, Abdulkader RS, 
Abebe Z, Abera SF, Abil OZ, Abraha HN, Abu-Raddad LJ, Abu-Rmeileh NME, 
Accrombessi MMK, Acharya D, Acharya P, Ackerman IN, Adamu AA, Adebayo OM, 
Adekanmbi V, Adetokunboh OO, Adib MG, Adsuar JC, Afanvi KA, Afarideh M, Afshin 
A, Agarwal G, Agesa KM, Aggarwal R, Aghayan SA, Agrawal S, Ahmadi A, Ahmadi M, 
Ahmadieh H, Ahmed MB, Aichour AN, Aichour I, Aichour MTE, Akinyemiju T, Akseer 
N, Al-Aly Z, Al-Eyadhy A, Al-Mekhlafi HM, Al-Raddadi RM, Alahdab F, Alam K, Alam 
T, Alashi A, Alavian SM, Alene KA, Alijanzadeh M, Alizadeh-Navaei R, Aljunid SM, 
Alkerwi A, Alla F, Allebeck P, Alouani MML, Altirkawi K, Alvis-Guzman N, Amare 
AT, Aminde LN, Ammar W, Amoako YA, Anber NH, Andrei CL, Androudi S, Animut MD, 
Anjomshoa M, Ansha MG, Antonio CAT, Anwari P, Arabloo J, Arauz A, Aremu O, 
Ariani F, Armoon B, Ärnlöv J, Arora A, Artaman A, Aryal KK, Asayesh H, Asghar 
RJ, Ataro Z, Atre SR, Ausloos M, Avila-Burgos L, Avokpaho EFGA, Awasthi A, Ayala 
Quintanilla BP, Ayer R, Azzopardi PS, Babazadeh A, Badali H, Badawi A, Bali AG, 
Ballesteros KE, Ballew SH, Banach M, Banoub JAM, Banstola A, Barac A, Barboza 
MA, Barker-Collo SL, Bärnighausen TW, Barrero LH, Baune BT, Bazargan-Hejazi S, 
Bedi N, Beghi E, Behzadifar M, Behzadifar M, Béjot Y, Belachew AB, Belay YA, 
Bell ML, Bello AK, Bensenor IM, Bernabe E, Bernstein RS, Beuran M, Beyranvand T, 
Bhala N, Bhattarai S, Bhaumik S, Bhutta ZA, Biadgo B, Bijani A, Bikbov B, Bilano 
V, Bililign N, Bin Sayeed MS, Bisanzio D, Blacker BF, Blyth FM, Bou-Orm IR, 
Boufous S, Bourne R, Brady OJ, Brainin M, Brant LC, Brazinova A, Breitborde NJK, 
Brenner H, Briant PS, Briggs AM, Briko AN, Britton G, Brugha T, Buchbinder R, 
Busse R, Butt ZA, Cahuana-Hurtado L, Cano J, Cárdenas R, Carrero JJ, Carter A, 
Carvalho F, Castañeda-Orjuela CA, Castillo Rivas J, Castro F, Catalá-López F, 
Cercy KM, Cerin E, Chaiah Y, Chang AR, Chang HY, Chang JC, Charlson FJ, 
Chattopadhyay A, Chattu VK, Chaturvedi P, Chiang PP, Chin KL, Chitheer A, Choi 
JJ, Chowdhury R, Christensen H, Christopher DJ, Cicuttini FM, Ciobanu LG, 
Cirillo M, Claro RM, Collado-Mateo D, Cooper C, Coresh J, Cortesi PA, Cortinovis 
M, Costa M, Cousin E, Criqui MH, Cromwell EA, Cross M, Crump JA, Dadi AF, 
Dandona L, Dandona R, Dargan PI, Daryani A, Das Gupta R, Das Neves J, Dasa TT, 
Davey G, Davis AC, Davitoiu DV, De Courten B, De La Hoz FP, De Leo D, De Neve 
JW, Degefa MG, Degenhardt L, Deiparine S, Dellavalle RP, Demoz GT, Deribe K, 
Dervenis N, Des Jarlais DC, Dessie GA, Dey S, Dharmaratne SD, Dinberu MT, Dirac 
MA, Djalalinia S, Doan L, Dokova K, Doku DT, Dorsey ER, Doyle KE, Driscoll TR, 
Dubey M, Dubljanin E, Duken EE, Duncan BB, Duraes AR, Ebrahimi H, Ebrahimpour S, 
Echko MM, Edvardsson D, Effiong A, Ehrlich JR, El Bcheraoui C, El Sayed Zaki M, 
El-Khatib Z, Elkout H, Elyazar IRF, Enayati A, Endries AY, Er B, Erskine HE, 
Eshrati B, Eskandarieh S, Esteghamati A, Esteghamati S, Fakhim H, Fallah Omrani 
V, Faramarzi M, Fareed M, Farhadi F, Farid TA, Farinha CSES, Farioli A, Faro A, 
Farvid MS, Farzadfar F, Feigin VL, Fentahun N, Fereshtehnejad SM, Fernandes E, 
Fernandes JC, Ferrari AJ, Feyissa GT, Filip I, Fischer F, Fitzmaurice C, Foigt 
NA, Foreman KJ, Fox J, Frank TD, Fukumoto T, Fullman N, Fürst T, Furtado JM, 
Futran ND, Gall S, Ganji M, Gankpe FG, Garcia-Basteiro AL, Gardner WM, Gebre AK, 
Gebremedhin AT, Gebremichael TG, Gelano TF, Geleijnse JM, Genova-Maleras R, 
Geramo YCD, Gething PW, Gezae KE, Ghadiri K, Ghasemi Falavarjani K, 
Ghasemi-Kasman M, Ghimire M, Ghosh R, Ghoshal AG, Giampaoli S, Gill PS, Gill TK, 
Ginawi IA, Giussani G, Gnedovskaya EV, Goldberg EM, Goli S, Gómez-Dantés H, Gona 
PN, Gopalani SV, Gorman TM, Goulart AC, Goulart BNG, Grada A, Grams ME, Grosso 
G, Gugnani HC, Guo Y, Gupta PC, Gupta R, Gupta R, Gupta T, Gyawali B, Haagsma 
JA, Hachinski V, Hafezi-Nejad N, Haghparast Bidgoli H, Hagos TB, Hailu GB, 
Haj-Mirzaian A, Haj-Mirzaian A, Hamadeh RR, Hamidi S, Handal AJ, Hankey GJ, Hao 
Y, Harb HL, Harikrishnan S, Haro JM, Hasan M, Hassankhani H, Hassen HY, 
Havmoeller R, Hawley CN, Hay RJ, Hay SI, Hedayatizadeh-Omran A, Heibati B, 
Hendrie D, Henok A, Herteliu C, Heydarpour S, Hibstu DT, Hoang HT, Hoek HW, 
Hoffman HJ, Hole MK, Homaie Rad E, Hoogar P, Hosgood HD, Hosseini SM, 
Hosseinzadeh M, Hostiuc M, Hostiuc S, Hotez PJ, Hoy DG, Hsairi M, Htet AS, Hu G, 
Huang JJ, Huynh CK, Iburg KM, Ikeda CT, Ileanu B, Ilesanmi OS, Iqbal U, Irvani 
SSN, Irvine CMS, Islam SMS, Islami F, Jacobsen KH, Jahangiry L, Jahanmehr N, 
Jain SK, Jakovljevic M, Javanbakht M, Jayatilleke AU, Jeemon P, Jha RP, Jha V, 
Ji JS, Johnson CO, Jonas JB, Jozwiak JJ, Jungari SB, Jürisson M, Kabir Z, Kadel 
R, Kahsay A, Kalani R, Kanchan T, Karami M, Karami Matin B, Karch A, Karema C, 
Karimi N, Karimi SM, Kasaeian A, Kassa DH, Kassa GM, Kassa TD, Kassebaum NJ, 
Katikireddi SV, Kawakami N, Karyani AK, Keighobadi MM, Keiyoro PN, Kemmer L, 
Kemp GR, Kengne AP, Keren A, Khader YS, Khafaei B, Khafaie MA, Khajavi A, Khalil 
IA, Khan EA, Khan MS, Khan MA, Khang YH, Khazaei M, Khoja AT, Khosravi A, 
Khosravi MH, Kiadaliri AA, Kiirithio DN, Kim CI, Kim D, Kim P, Kim YE, Kim YJ, 
Kimokoti RW, Kinfu Y, Kisa A, Kissimova-Skarbek K, Kivimäki M, Knudsen AKS, 
Kocarnik JM, Kochhar S, Kokubo Y, Kolola T, Kopec JA, Kosen S, Kotsakis GA, Koul 
PA, Koyanagi A, Kravchenko MA, Krishan K, Krohn KJ, Kuate Defo B, Kucuk Bicer B, 
Kumar GA, Kumar M, Kyu HH, Lad DP, Lad SD, Lafranconi A, Lalloo R, Lallukka T, 
Lami FH, Lansingh VC, Latifi A, Lau KM, Lazarus JV, Leasher JL, Ledesma JR, Lee 
PH, Leigh J, Leung J, Levi M, Lewycka S, Li S, Li Y, Liao Y, Liben ML, Lim LL, 
Lim SS, Liu S, Lodha R, Looker KJ, Lopez AD, Lorkowski S, Lotufo PA, Low N, 
Lozano R, Lucas TCD, Lucchesi LR, Lunevicius R, Lyons RA, Ma S, Macarayan ERK, 
Mackay MT, Madotto F, Magdy Abd El Razek H, Magdy Abd El Razek M, Maghavani DP, 
Mahotra NB, Mai HT, Majdan M, Majdzadeh R, Majeed A, Malekzadeh R, Malta DC, 
Mamun AA, Manda AL, Manguerra H, Manhertz T, Mansournia MA, Mantovani LG, Mapoma 
CC, Maravilla JC, Marcenes W, Marks A, Martins-Melo FR, Martopullo I, März W, 
Marzan MB, Mashamba-Thompson TP, Massenburg BB, Mathur MR, Matsushita K, Maulik 
PK, Mazidi M, McAlinden C, McGrath JJ, McKee M, Mehndiratta MM, Mehrotra R, 
Mehta KM, Mehta V, Mejia-Rodriguez F, Mekonen T, Melese A, Melku M, Meltzer M, 
Memiah PTN, Memish ZA, Mendoza W, Mengistu DT, Mengistu G, Mensah GA, Mereta ST, 
Meretoja A, Meretoja TJ, Mestrovic T, Mezerji NMG, Miazgowski B, Miazgowski T, 
Millear AI, Miller TR, Miltz B, Mini GK, Mirarefin M, Mirrakhimov EM, Misganaw 
AT, Mitchell PB, Mitiku H, Moazen B, Mohajer B, Mohammad KA, Mohammadifard N, 
Mohammadnia-Afrouzi M, Mohammed MA, Mohammed S, Mohebi F, Moitra M, Mokdad AH, 
Molokhia M, Monasta L, Moodley Y, Moosazadeh M, Moradi G, Moradi-Lakeh M, 
Moradinazar M, Moraga P, Morawska L, Moreno Velásquez I, Morgado-Da-Costa J, 
Morrison SD, Moschos MM, Mousavi SM, Mruts KB, Muche AA, Muchie KF, Mueller UO, 
Muhammed OS, Mukhopadhyay S, Muller K, Mumford JE, Murhekar M, Musa J, Musa KI, 
Mustafa G, Nabhan AF, Nagata C, Naghavi M, Naheed A, Nahvijou A, Naik G, Naik N, 
Najafi F, Naldi L, Nam HS, Nangia V, Nansseu JR, Nascimento BR, Natarajan G, 
Neamati N, Negoi I, Negoi RI, Neupane S, Newton CRJ, Ngunjiri JW, Nguyen AQ, 
Nguyen HT, Nguyen HLT, Nguyen HT, Nguyen LH, Nguyen M, Nguyen NB, Nguyen SH, 
Nichols E, Ningrum DNA, Nixon MR, Nolutshungu N, Nomura S, Norheim OF, Noroozi 
M, Norrving B, Noubiap JJ, Nouri HR, Nourollahpour Shiadeh M, Nowroozi MR, 
Nsoesie EO, Nyasulu PS, Odell CM, Ofori-Asenso R, Ogbo FA, Oh IH, Oladimeji O, 
Olagunju AT, Olagunju TO, Olivares PR, Olsen HE, Olusanya BO, Ong KL, Ong SK, 
Oren E, Ortiz A, Ota E, Otstavnov SS, Øverland S, Owolabi MO, P A M, Pacella R, 
Pakpour AH, Pana A, Panda-Jonas S, Parisi A, Park EK, Parry CDH, Patel S, Pati 
S, Patil ST, Patle A, Patton GC, Paturi VR, Paulson KR, Pearce N, Pereira DM, 
Perico N, Pesudovs K, Pham HQ, Phillips MR, Pigott DM, Pillay JD, Piradov MA, 
Pirsaheb M, Pishgar F, Plana-Ripoll O, Plass D, Polinder S, Popova S, Postma MJ, 
Pourshams A, Poustchi H, Prabhakaran D, Prakash S, Prakash V, Purcell CA, Purwar 
MB, Qorbani M, Quistberg DA, Radfar A, Rafay A, Rafiei A, Rahim F, Rahimi K, 
Rahimi-Movaghar A, Rahimi-Movaghar V, Rahman M, Rahman MHU, Rahman MA, Rahman 
SU, Rai RK, Rajati F, Ram U, Ranjan P, Ranta A, Rao PC, Rawaf DL, Rawaf S, Reddy 
KS, Reiner RC, Reinig N, Reitsma MB, Remuzzi G, Renzaho AMN, Resnikoff S, Rezaei 
S, Rezai MS, Ribeiro ALP, Robinson SR, Roever L, Ronfani L, Roshandel G, Rostami 
A, Roth GA, Roy A, Rubagotti E, Sachdev PS, Sadat N, Saddik B, Sadeghi E, Saeedi 
Moghaddam S, Safari H, Safari Y, Safari-Faramani R, Safdarian M, Safi S, Safiri 
S, Sagar R, Sahebkar A, Sahraian MA, Sajadi HS, Salam N, Salama JS, Salamati P, 
Saleem K, Saleem Z, Salimi Y, Salomon JA, Salvi SS, Salz I, Samy AM, Sanabria J, 
Sang Y, Santomauro DF, Santos IS, Santos JV, Santric Milicevic MM, Sao Jose BP, 
Sardana M, Sarker AR, Sarrafzadegan N, Sartorius B, Sarvi S, Sathian B, Satpathy 
M, Sawant AR, Sawhney M, Saxena S, Saylan M, Schaeffner E, Schmidt MI, Schneider 
IJC, Schöttker B, Schwebel DC, Schwendicke F, Scott JG, Sekerija M, Sepanlou SG, 
Serván-Mori E, Seyedmousavi S, Shabaninejad H, Shafieesabet A, Shahbazi M, 
Shaheen AA, Shaikh MA, Shams-Beyranvand M, Shamsi M, Shamsizadeh M, Sharafi H, 
Sharafi K, Sharif M, Sharif-Alhoseini M, Sharma M, Sharma R, She J, Sheikh A, 
Shi P, Shibuya K, Shigematsu M, Shiri R, Shirkoohi R, Shishani K, Shiue I, 
Shokraneh F, Shoman H, Shrime MG, Si S, Siabani S, Siddiqi TJ, Sigfusdottir ID, 
Sigurvinsdottir R, Silva JP, Silveira DGA, Singam NSV, Singh JA, Singh NP, Singh 
V, Sinha DN, Skiadaresi E, Slepak ELN, Sliwa K, Smith DL, Smith M, Soares Filho 
AM, Sobaih BH, Sobhani S, Sobngwi E, Soneji SS, Soofi M, Soosaraei M, Sorensen 
RJD, Soriano JB, Soyiri IN, Sposato LA, Sreeramareddy CT, Srinivasan V, Stanaway 
JD, Stein DJ, Steiner C, Steiner TJ, Stokes MA, Stovner LJ, Subart ML, 
Sudaryanto A, Sufiyan MB, Sunguya BF, Sur PJ, Sutradhar I, Sykes BL, Sylte DO, 
Tabarés-Seisdedos R, Tadakamadla SK, Tadesse BT, Tandon N, Tassew SG, Tavakkoli 
M, Taveira N, Taylor HR, Tehrani-Banihashemi A, Tekalign TG, Tekelemedhin SW, 
Tekle MG, Temesgen H, Temsah MH, Temsah O, Terkawi AS, Teweldemedhin M, 
Thankappan KR, Thomas N, Tilahun B, To QG, Tonelli M, Topor-Madry R, Topouzis F, 
Torre AE, Tortajada-Girbés M, Touvier M, Tovani-Palone MR, Towbin JA, Tran BX, 
Tran KB, Troeger CE, Truelsen TC, Tsilimbaris MK, Tsoi D, Tudor Car L, Tuzcu EM, 
Ukwaja KN, Ullah I, Undurraga EA, Unutzer J, Updike RL, Usman MS, Uthman OA, 
Vaduganathan M, Vaezi A, Valdez PR, Varughese S, Vasankari TJ, 
Venketasubramanian N, Villafaina S, Violante FS, Vladimirov SK, Vlassov V, 
Vollset SE, Vosoughi K, Vujcic IS, Wagnew FS, Waheed Y, Waller SG, Wang Y, Wang 
YP, Weiderpass E, Weintraub RG, Weiss DJ, Weldegebreal F, Weldegwergs KG, 
Werdecker A, West TE, Whiteford HA, Widecka J, Wijeratne T, Wilner LB, Wilson S, 
Winkler AS, Wiyeh AB, Wiysonge CS, Wolfe CDA, Woolf AD, Wu S, Wu YC, Wyper GMA, 
Xavier D, Xu G, Yadgir S, Yadollahpour A, Yahyazadeh Jabbari SH, Yamada T, Yan 
LL, Yano Y, Yaseri M, Yasin YJ, Yeshaneh A, Yimer EM, Yip P, Yisma E, Yonemoto 
N, Yoon SJ, Yotebieng M, Younis MZ, Yousefifard M, Yu C, Zadnik V, Zaidi Z, 
Zaman SB, Zamani M, Zare Z, Zeleke AJ, Zenebe ZM, Zhang K, Zhao Z, Zhou M, 
Zodpey S, Zucker I, Vos T, Murray CJL.

Erratum in
    Lancet. 2019 Jun 22;393(10190):e44.

BACKGROUND: The Global Burden of Diseases, Injuries, and Risk Factors Study 2017 
(GBD 2017) includes a comprehensive assessment of incidence, prevalence, and 
years lived with disability (YLDs) for 354 causes in 195 countries and 
territories from 1990 to 2017. Previous GBD studies have shown how the decline 
of mortality rates from 1990 to 2016 has led to an increase in life expectancy, 
an ageing global population, and an expansion of the non-fatal burden of disease 
and injury. These studies have also shown how a substantial portion of the 
world's population experiences non-fatal health loss with considerable 
heterogeneity among different causes, locations, ages, and sexes. Ongoing 
objectives of the GBD study include increasing the level of estimation detail, 
improving analytical strategies, and increasing the amount of high-quality data.
METHODS: We estimated incidence and prevalence for 354 diseases and injuries and 
3484 sequelae. We used an updated and extensive body of literature studies, 
survey data, surveillance data, inpatient admission records, outpatient visit 
records, and health insurance claims, and additionally used results from cause 
of death models to inform estimates using a total of 68 781 data sources. Newly 
available clinical data from India, Iran, Japan, Jordan, Nepal, China, Brazil, 
Norway, and Italy were incorporated, as well as updated claims data from the USA 
and new claims data from Taiwan (province of China) and Singapore. We used 
DisMod-MR 2.1, a Bayesian meta-regression tool, as the main method of 
estimation, ensuring consistency between rates of incidence, prevalence, 
remission, and cause of death for each condition. YLDs were estimated as the 
product of a prevalence estimate and a disability weight for health states of 
each mutually exclusive sequela, adjusted for comorbidity. We updated the 
Socio-demographic Index (SDI), a summary development indicator of income per 
capita, years of schooling, and total fertility rate. Additionally, we 
calculated differences between male and female YLDs to identify divergent trends 
across sexes. GBD 2017 complies with the Guidelines for Accurate and Transparent 
Health Estimates Reporting.
FINDINGS: Globally, for females, the causes with the greatest age-standardised 
prevalence were oral disorders, headache disorders, and haemoglobinopathies and 
haemolytic anaemias in both 1990 and 2017. For males, the causes with the 
greatest age-standardised prevalence were oral disorders, headache disorders, 
and tuberculosis including latent tuberculosis infection in both 1990 and 2017. 
In terms of YLDs, low back pain, headache disorders, and dietary iron deficiency 
were the leading Level 3 causes of YLD counts in 1990, whereas low back pain, 
headache disorders, and depressive disorders were the leading causes in 2017 for 
both sexes combined. All-cause age-standardised YLD rates decreased by 3·9% (95% 
uncertainty interval [UI] 3·1-4·6) from 1990 to 2017; however, the all-age YLD 
rate increased by 7·2% (6·0-8·4) while the total sum of global YLDs increased 
from 562 million (421-723) to 853 million (642-1100). The increases for males 
and females were similar, with increases in all-age YLD rates of 7·9% (6·6-9·2) 
for males and 6·5% (5·4-7·7) for females. We found significant differences 
between males and females in terms of age-standardised prevalence estimates for 
multiple causes. The causes with the greatest relative differences between sexes 
in 2017 included substance use disorders (3018 cases [95% UI 2782-3252] per 
100 000 in males vs s1400 [1279-1524] per 100 000 in females), transport 
injuries (3322 [3082-3583] vs 2336 [2154-2535]), and self-harm and interpersonal 
violence (3265 [2943-3630] vs 5643 [5057-6302]).
INTERPRETATION: Global all-cause age-standardised YLD rates have improved only 
slightly over a period spanning nearly three decades. However, the magnitude of 
the non-fatal disease burden has expanded globally, with increasing numbers of 
people who have a wide spectrum of conditions. A subset of conditions has 
remained globally pervasive since 1990, whereas other conditions have displayed 
more dynamic trends, with different ages, sexes, and geographies across the 
globe experiencing varying burdens and trends of health loss. This study 
emphasises how global improvements in premature mortality for select conditions 
have led to older populations with complex and potentially expensive diseases, 
yet also highlights global achievements in certain domains of disease and 
injury.
FUNDING: Bill & Melinda Gates Foundation.

Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open 
Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All 
rights reserved.

DOI: 10.1016/S0140-6736(18)32279-7
PMCID: PMC6227754
PMID: 30496104 [Indexed for MEDLINE]


17. Lancet. 2018 Nov 10;392(10159):1923-1994. doi: 10.1016/S0140-6736(18)32225-6.
 Epub 2018 Nov 8.

Global, regional, and national comparative risk assessment of 84 behavioural, 
environmental and occupational, and metabolic risks or clusters of risks for 195 
countries and territories, 1990-2017: a systematic analysis for the Global 
Burden of Disease Study 2017.

GBD 2017 Risk Factor Collaborators.

Collaborators: Stanaway JD, Afshin A, Gakidou E, Lim SS, Abate D, Abate KH, 
Abbafati C, Abbasi N, Abbastabar H, Abd-Allah F, Abdela J, Abdelalim A, 
Abdollahpour I, Abdulkader RS, Abebe M, Abebe Z, Abera SF, Abil OZ, Abraha HN, 
Abrham AR, Abu-Raddad LJ, Abu-Rmeileh NM, Accrombessi MMK, Acharya D, Acharya P, 
Adamu AA, Adane AA, Adebayo OM, Adedoyin RA, Adekanmbi V, Ademi Z, Adetokunboh 
OO, Adib MG, Admasie A, Adsuar JC, Afanvi KA, Afarideh M, Agarwal G, Aggarwal A, 
Aghayan SA, Agrawal A, Agrawal S, Ahmadi A, Ahmadi M, Ahmadieh H, Ahmed MB, 
Aichour AN, Aichour I, Aichour MTE, Akbari ME, Akinyemiju T, Akseer N, Al-Aly Z, 
